ArticleInternational journal of hematology2022

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan.

Takayuki Ikezoe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.